Original version

BBC World Service Australasia

Business Daily

Factual: Money

The daily drama of money and work from the BBC.

BBC World Service East and Southern Africa Schedule

BBC World Service East and Southern Africa

BBC World Service Online

BBC World Service schedule for American satellite radio and the Caribbean

BBC World Service Americas and the Caribbean

BBC World Service

BBC World Service South Asia

BBC World Service News Internet

BBC World Service Europe and the Middle East

BBC World Service West and Central Africa Schedule

BBC World Service West and Central Africa

BBC World Service East Asia

Business Daily: The weight-loss drug revolution

Bulletins

The weight-loss drug revolution

07/06/2024 GMT

BBC World Service - Business Daily, The weight-loss drug revolution

How anti-obesity and diabetes drugs like Ozempic are revolutionising the pharma industry

Two companies dominate the market for diabetes and weight loss drugs. But with competitors desperate for a piece of the action, how long can they stay in front?

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of Mounjaro. But with competitors desperate for a piece of the action, how long can these two giants stay in front?

Leanna Byrne hears from some of the companies involved, including those at the centre of the action and those developing the next wave of treatments.

Presented by Leanna Byrne and produced by Lexy O'Connor

(Image: A box of the anti-obesity drug Wegovy, including injection pens. Credit: Getty Images)

Accessibility links

Programme Index

Business Daily

The weight-loss drug revolution

Genres

Formats

Brand

BBC World Service Australasia

About BBC World Service